Home > Healthcare > Medical Devices > Infection Control > Endoscope Reprocessing Market

Endoscope Reprocessing Market - By Product Type (Devices [AERs, Endoscope Drying, Storage, Transport Systems], Consumables [Valves & Adaptors, HLD, Bedside Kits], Accessories), End-Use (Hospitals, Ambulatory Surgical Centers), Forecast, 2024 – 2032

  • Report ID: GMI10131
  • Published Date: Jul 2024
  • Report Format: PDF

Endoscope Reprocessing Market Size

Endoscope Reprocessing Market size was valued at around USD 2.9 billion in 2023 and is estimated to grow at 11.5% CAGR from 2024 to 2032. The rising prevalence of gastrointestinal diseases, cancer, and other medical conditions requiring diagnostic and therapeutic endoscopic procedures is a significant driver for the market.

Endoscope Reprocessing Market

For instance, according to an article published in 2024 by the American Society of Anesthesiologists, approximately 6.1 million upper endoscopies are performed annually in the U.S. As endoscopic procedures become more common for both diagnostic and interventional purposes, the need for effective and efficient reprocessing of endoscopes and accessories also increases.

Moreover, the focus on effective reprocessing of endoscopes is driven by the need to enhance patient safety and reduce the risk of healthcare-acquired infections. Regulatory bodies and organizations issue stringent guidelines to ensure the reliability of reprocessing procedures. With the rise of multidrug-resistant pathogens and increased scrutiny on infection control, thorough cleaning, disinfection, and validation processes are essential, hence driving the market growth.

Endoscope reprocessing is the systematic process of cleaning, disinfecting, and sterilizing endoscopes to ensure they are safe for reuse. This process includes several stages such as pre-cleaning, leak testing, manual cleaning, high-level disinfection or sterilization, rinsing, and drying. It is crucial for preventing cross-contamination and healthcare-associated infections.

Endoscope Reprocessing Market Trends

The landscape of endoscope reprocessing is being reshaped by rapid advancements in medical technology, indicating a new era of precision cleaning and personalized reprocessing strategies.

  • Advancements in high-level disinfection (HLD) solutions have improved the effectiveness of endoscope reprocessing. Innovations such as peracetic acid, hydrogen peroxide-based sterilizers, and ozone-based systems provide superior microbial kill rates and shorter cycle times.
  • The integration of smart technologies, such as IoT and AI, in AERs to monitor and optimize the reprocessing cycle is expected to boost the market growth over the forecast period. These systems can provide real-time data, predictive maintenance alerts, and ensure compliance with reprocessing protocols.
  • Additionally, the introduction of enhanced automation capabilities to reduce human mistake and increase efficiency is expected to boost market growth. Advanced AERs now include capabilities such as automated leak testing, detergent dosing, and comprehensive disinfection cycles.
  • Moreover, the market is being shaped by a combination of technological innovation, regulatory pressures, and a heightened focus on patient safety and environmental sustainability. As healthcare providers strive to improve infection control and comply with stricter guidelines, the demand for advanced, efficient, and eco-friendly reprocessing solutions is expected to continue growing.

Endoscope Reprocessing Market Analysis

Endoscope Reprocessing Market, By Product Type, 2021 – 2032 (USD Billion)

Based on product type, the market is categorized into devices, consumables, and accessories. The devices segment dominated the market with the revenue of USD 1.9 billion in 2023.

  • The growing use of endoscopic procedures in diagnostic and therapeutic applications increases the need for efficient reprocessing devices. AERs, for instance, can handle higher volumes of endoscopes, meeting the demands of busy healthcare facilities.
  • Furthermore, reprocessing devices typically represent a significant capital investment for hospitals and clinics. Their high cost compared to consumables and accessories contributes to the larger revenue share of this segment.

Endoscope Reprocessing Market, By End-use (2023)

Based on end-use, the endoscope reprocessing market is segmented into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for USD 1.7 billion in 2023.

  • Hospitals are critical environments for the reprocessing of endoscopes due to the high volume of endoscopic procedures they conduct and the imperative need for stringent infection control measures. Effective endoscope reprocessing in hospitals is driven by several key factors, each contributing to the overall goal of ensuring patient safety and operational efficiency.
  • Additionally, hospitals play a pivotal role in the market, driven by a need for stringent infection control, regulatory compliance, technological advancements, and operational efficiency. This will be further supported by ongoing innovations, economic considerations, and a commitment to sustainable and eco-friendly practices. These factors are anticipated to propel the growth of the ambulatory surgical centers segment.

North America Endoscope Reprocessing Market, 2021 – 2032 (USD Billion)

North America dominated the endoscope reprocessing market and is poised to reach USD 3.2 billion by 2032. The region's dominance can be attributed to several factors, including the increasing incidence of gastrointestinal diseases, cancers, and other chronic conditions that necessitate endoscopic procedures.

  • For instance, according to the Center for Chronic Disease Prevention (CDC), approximately 129 million individuals in the U.S. suffer from at least one major chronic condition ultimately driving the need for endoscope reprocessing solutions.
  • Moreover, governments in the region are increasingly prioritizing the improvement of healthcare infrastructure and patient safety. For example, the FDA has been actively raising awareness about the risks of infections associated with reprocessed urological endoscopes, building on their experience with duodenoscopes since 2015.

The U.S. endoscope reprocessing market is anticipated to reach USD 1.2 billion by 2032, driven by a combination of technological advancements, regulatory compliance, patient safety concerns, and operational efficiency needs.

  • The U.S. market is heavily influenced by stringent guidelines from regulatory bodies such as the FDA, Society of Gastroenterology Nurses, and Associates (SGNA), among others. These guidelines mandate rigorous cleaning, disinfection, and sterilization processes to prevent infections.
  • Furthermore, as healthcare facilities continue to prioritize infection control and strive for operational excellence, the adoption of advanced reprocessing devices and practices is expected to grow. These factors are expected to boost the U.S. market growth over the forecast period.

The endoscope reprocessing market in UK is expected to experience significant and promising growth from 2024 to 2032.

  • There is considerable emphasis on minimizing healthcare-associated infections (HAIs) in the UK. The meticulous reprocessing of endoscopes is vital for preventing these infections, thereby ensuring patient safety, and maintaining public confidence in healthcare institutions.
  • The increasing awareness among patients and the general public regarding the risks linked to endoscopic procedures has amplified the demand for high-quality reprocessing practices in the region.

Japan endoscope reprocessing market is anticipated to witness lucrative growth between 2024 – 2032.

  • Japanese healthcare facilities often align with international standards and best practices from organizations such as the World Health Organization (WHO) and the European Society of Gastrointestinal Endoscopy (ESGE), further emphasizing the need for high-quality reprocessing practices.
  • Furthermore, as Japanese healthcare facilities continue to prioritize infection control and strive for operational excellence, the adoption of advanced reprocessing devices and practices is expected to grow. This regional growth will be supported by ongoing innovations, economic considerations, and a commitment to sustainable and eco-friendly practices.

Endoscope Reprocessing Market Share

The global market for endoscope reprocessing is highly competitive, driven by the increasing demand for infection control measures, advancements in technology, and stringent regulatory guidelines. Key players in this market are focusing on product innovation, strategic partnerships, mergers and acquisitions, and geographic expansion to maintain and enhance their market position. As the demand for effective infection control measures continues to grow, driven by regulatory compliance and patient safety concerns, the adoption of advanced reprocessing technologies and sustainable practices is expected to increase, shaping the future of the market.

Endoscope Reprocessing Market Companies

Some of the eminent market participants operating in the endoscope reprocessing industry include:

  • ARC Group of Companies Inc.
  • ASP
  • Belimed
  • CONMED Corporation
  • Creo Medical
  • Ecolab
  • Getinge AB
  • Karl Storz
  • Metrex Research, LLC.
  • Olympus Corporation
  • Shinva Medical Intrument Co., Ltd
  • Steelco S.p.A.
  • Wassenburg Medical B.V.

Endoscope Reprocessing Industry News:

  • In February 2024, Olympus Corporation announced the launch of Olympus ETD, available in two versions: ETD Basic and ETD Premium. The latest addition to the company's infection prevention portfolio has been designed to enhance the efficiency and sustainability of endoscope reprocessing while providing superior cleaning and disinfection results. Healthcare professionals will benefit from improved usability and a streamlined process, resulting in a reduced workload.
  • In June 2022, Getinge AB released an updated version of the ED-Flow automated endoscope reprocessor. The new features enhanced the digital connectivity and data management for Getinge’s endoscope reprocessing customers, leading to improved uptime and increased productivity.

The endoscope reprocessing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

  • Devices
  • Automated endoscope reprocessors (AERs)
    • Single door AERs
    • Double door AERs
  • Endoscope drying, storage, and transport systems
  • Other devices 
  • Consumables
    • High level disinfectants (HLD)
    • Valves & adaptors
    • Bedside kits
    • Other consumables
  • Accessories

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Other end-users

The above information is provided for the following regions and countries:

  • North America 
    • U.S.
    • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Switzerland
  • CEE
    • Poland
    • Hungary
    • Romania
    • Czech Republic
    • Bulgaria
    • Rest of CEE
  • Nordic countries
    • Denmark
    • Sweden
    • Norway
    • Rest of Nordic countries
  • Rest of Europe
    • Asia Pacific 
    • China
    • Japan
    • India
    • Australia & NewZealand
    • South Korea
    • Rest of Asia Pacific
  • Latin America 
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa 
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global endoscope reprocessing delivery industry was valued at USD 2.9 billion in 2023 and is anticipated to register 11.5% CAGR between 2024 and 2032, driven by the rising prevalence of gastrointestinal diseases, cancer, and other medical conditions.

The devices segment in the market was valued at USD 1.9 billion in 2023, owing to the growing use of endoscopic procedures in diagnostic and therapeutic applications.

North America endoscope reprocessing market is poised to reach USD 3.2 billion by 2032, attributed to the increasing incidence of gastrointestinal diseases, cancers, and other chronic conditions.

ARC Group of Companies Inc., ASP, Belimed, CONMED Corporation, Creo Medical, Ecolab, Getinge AB, Karl Storz, Metrex Research, LLC., and Olympus Corporation, among others.

Endoscope Reprocessing Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 243
  • Countries covered: 36
  • Pages: 100
 Download Free Sample